Rheumatoid Arthritis Memory B Cells and Abatacept (RAMBA)
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Single-Open Label Study to Assess Changes in the Immune Profile in Response to Treatment with
Intravenous Abatacept Adults with Rheumatoid Arthritis who are Naive to Biologic
Disease-Modifying Antirheumatic Drugs
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health